Prone Positioning Falls Flat for Weaning COVID Patients Off ECMO
Early application of prone positioning did not help patients with severe acute respiratory distress syndrome (ARDS) -- mostly from COVID -- get off venovenous extracorporeal membrane oxygenation (VV-ECMO) any faster…
Rare Syndrome After COVID Vaccines Described
People who experienced rare long-term adverse events after COVID-19 vaccination often had neurologic symptoms, survey data showed. Among 241 people who self-reported a post-vaccination syndrome (PVS), the five most common…
‘Alexa, Titrate My Insulin’: AI App Boosts Glycemic Control in Randomized Trial
A custom artificial intelligence (AI) app for insulin management advice helped patients with type 2 diabetes gain rapid glycemic control, a small randomized clinical trial found. In titrating basal insulin,…
Two-Week Prophylaxis May Prevent Hep C After Kidney Transplant
Short-term prophylaxis with direct-acting antivirals was fully effective at protecting kidney transplant recipients when their donors had hepatitis C, a proof-of-concept study showed. In the small, uncontrolled trial, a 2-week…
Let’s Talk Drug Prices; Restoring the Sense of Touch; Learning From Tumors in a Dish
Sen. Bernie Sanders (I-Vt.) has invited CEOs of Johnson & Johnson, Merck, and Bristol Myers Squibb to testify next month at a hearing on drug pricing, specifically to discuss why…
Managing the Safety of Newer Atopic Dermatitis Treatments
MedPage Today brought together three expert leaders for a virtual roundtable discussion on atopic dermatitis : Moderator Peter Lio, MD, of Northwestern University Feinberg School of Medicine in Chicago, is…
Biologics Offer New Options in Atopic Dermatitis
In this exclusive MedPage Today video, Peter Lio, MD, of Northwestern University Feinberg School of Medicine in Chicago, talks about how excited he is to have new and upcoming treatments…
A World AIDS Day Reminder: No One Should Be Left Behind
Guilamo-Ramos is a nurse and HIV/AIDS researcher. As a nurse who has for decades provided clinical care and conducted research on the challenges faced by individuals at risk for and…
Oncolytic Virus Shows High Response Rates in BCG-Unresponsive Bladder Cancer
WASHINGTON -- Treatment with cretostimogene grenadenorepvec, an investigational intravesically delivered oncolytic immunotherapy, achieved high response rates in patients with high-risk non-muscle-invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guérin (BCG), according…
Swapping the White Coat for a Space Suit
Welcome to "Medical Mavericks," a new series from MedPage Today featuring interviews with healthcare professionals working in unconventional fields of health and medicine. We spoke with Anna Fisher, MD, MS,…
